The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management-Reference-Cited by-同舟云学术

The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management

Published:2014-07-09 Issue:11 Volume:122 Page:842-850
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathology

Author:

Gage Julia C.¹,Katki Hormuzd A.¹,Schiffman Mark¹,Castle Philip E.²,Fetterman Barbara³,Poitras Nancy E.³,Lorey Thomas³,Cheung Li C.⁴,Behrens Catherine⁵,Sharma Abha⁵,Zhao Fang-Hui⁶,Cuzick Jack⁷,Yang Zi Hua⁷,Kinney Walter K.⁸

Affiliation:

1. Division of Cancer Epidemiology and Genetics; National Cancer Institute, National Institutes of Health, Department of Health and Human Services; Bethesda Maryland

2. Global Cancer Initiative; Chestertown Maryland

3. Regional Laboratory; Kaiser Permanente Northern California; Berkeley California

4. Information Management Services Inc; Calverton Maryland

5. Roche Molecular Systems; Pleasanton California

6. Department of Epidemiology; Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China

7. Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London; London United Kingdom

8. Division of Gynecologic Oncology; Kaiser Permanente Medical Care Program; Oakland California

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology;Davey;Arch Pathol Lab Med,2004

2. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines;Solomon;CA Cancer J Clin,2007

3. The 2001 Bethesda System: terminology for reporting results of cervical cytology;Solomon;JAMA,2002

4. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study;Stoler;JAMA,2001

5. Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trial;Wright;Int J Cancer,2014

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern approaches to cervical cancer screening (a review);Pathologia;2023-04-28

2. Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States;International Journal of Cancer;2023-04-07

3. Redesign of a rapid, low‐cost HPV typing assay to support risk‐based cervical screening and management;International Journal of Cancer;2022-06-24

4. The development of “automated visual evaluation” for cervical cancer screening: The promise and challenges in adapting deep‐learning for clinical testing;International Journal of Cancer;2021-12-06

5. Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS);Journal of Clinical Virology;2021-12